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SUMMARY 
 The hospital setting introduces a number of challenges to 
implementing this type of intervention, including recruitment 
barriers and high attrition rates.  
 Patient engagement in smoking cessation is likely to be 
affected by the reason for admission and patients’ stage of 
change 
 To be successful, smoking cessation interventions may 
need to be tailored to the patients’ degree of motivation, as 
evidenced by their stage of change 
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ABSTRACT 
Background  
Young adults are reluctant to use evidence-based smoking 
cessation interventions. Subsequently, they are less 
successful at giving up smoking compared to older adults. 
This highlights the need for innovative strategies to 
engage young people in smoking cessation. A novel 
intervention using photoageing technology has been 
shown to be an effective trigger for smoking cessation. 
 
Aims 
To conduct a pilot study deploying photoageing 
technology to trigger smoking cessation attempts in 
young adults admitted to hospital. 
 
Method 
A randomised controlled trial was designed. Thirty 
participants were recruited from a regional hospital in 
Melbourne, Australia. Participants were allocated to the 
intervention and control groups on alternate weeks. All 
participants received brief smoking cessation advice. The 
intervention group was digitally aged using the APRIL 
Face Aging Software. The primary outcomes were 
measured at six weeks’ post-intervention and included 
number of quit attempts, nicotine dependence, and 
progression through the stages of change model. 
 
Results 
At six weeks’ post-intervention, there was no difference 
in quit attempts between the two groups (Mann-Whitney 
U=111 and p=0.484). There was also no difference in 
nicotine dependence (Mann-Whitney U=106 and 
p=0.403) or stage of change (2=1.71 and p=0.634) 
between the groups. 
 
Conclusion 
Hospitalisation is associated with a number of barriers, 
which prevent the implementation of photoageing 
technology in this setting. Of these barriers, participant 
recruitment and retention pose the greatest challenge. 
Due to these considerations, it was not possible to 
demonstrate an effect size with any confidence. 
 
BACKGROUND 
Cigarette smoke is the leading cause of preventable death 
and disease in Australia.1 It claims the lives of 
approximately 15,000 Australians each year and is 
responsible for 1 in 10 deaths.2 Since 1995, the number 
of young adult smokers in Australia has more than 
halved.3 Despite this improvement, 1 in 5 adults aged 18–
30 still smoke. Of these smokers, approximately 70 per 
cent smoke daily.3,4  
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Addressing the issue of smoking in the young adult 
population is imperative to prevent the long-term 
sequelae associated with cigarette smoke. However, 
triggering behavioural change in young adult smokers 
poses many challenges. They are less successful at quitting 
compared to older smokers and underutilise evidence-
based smoking cessation interventions.5,6 Given these 
difficulties, clinicians must find innovative ways to engage 
young people in smoking cessation. 
 
Generation Y is known for its love of technology. 
Recently, researchers have harnessed the power of 
technology to engage young people in smoking cessation. 
The use of Internet-based interventions, mobile phone 
applications, and social media interventions have yielded 
mixed results.7–9 However, a novel intervention using 
photoageing technology has been shown to be an effective 
trigger for behavioural change.10,11 The intervention 
involves taking a picture of the participant’s face, and 
digitally ageing the image through the use of 
wrinkling/ageing algorithms to produce a picture of the 
participant as an aged smoker. When implemented in a 
community pharmacy setting, the intervention reduced 
nicotine dependence and produced significantly more 
quit attempts when compared to smoking cessation 
advice alone.10  
 
It may not be technology alone that will deliver a 
successful intervention. A combination of technology 
and timing may provide the key to triggering behavioural 
change in this population. The literature suggests that 
timing is the key to triggering behavioural change. An 
intervention must be delivered at a time when the patient 
is open to advice—a concept known as a “teachable 
moment”. A teachable moment is defined as the point at 
which a health event motivates the patient to adopt a risk-
reducing behaviour.12 Previous research has 
demonstrated hospitalisation to be a powerful teachable 
moment with regard to smoking cessation.13 It represents 
a unique opportunity, where patients are primed and 
ready to quit smoking.  
 
This study hypothesises that people presenting to hospital 
will have a greater sense of being vulnerable to serious 
pathology and more likely to attempt to stop smoking. 
Furthermore, we hypothesise that the intervention will 
trigger more quit attempts and reduce nicotine 
dependence compared to usual care. 
OBJECTIVE 
A pilot study deploying photoageing technology to trigger 
smoking cessation attempts in young adults admitted to 
hospital. 
 
METHOD 
This study obtained approval from Mercy Health HREC. 
Project reference number: R16/25W. The methods 
described below replicate the methods deployed in a 
previous large scale randomised trial.10 
 
Recruitment 
A pilot randomised controlled trial was conducted. 
Thirty participants were recruited from a large regional 
hospital located in the western suburbs of Melbourne, 
Australia. Participants were recruited according to the 
following eligibility criteria: male or female smokers, aged 
18–35, admission to the medical or surgical ward or 
emergency department, not using any smoking cessation 
medication or therapy, able to give consent and no beards 
or facial piercings that cannot be removed. Participants 
recruited to the study were allocated to the control group 
and intervention group on alternate weeks in order to 
minimise selection bias and contamination between the 
groups. At the conclusion of recruitment, there were 15 
participants in the control group and 15 in the 
intervention group. 
 
Sample Size 
A sample size of 15 participants per group was required 
to confirm a moderate effect size (d=0.14) within 95% 
confidence intervals.14 
 
Baseline Questionnaire 
On commencement, all participants completed a baseline 
questionnaire, which included demographic 
information, and baseline measures of the primary 
outcomes measures for nicotine dependence and stage of 
change. The Fagerström Smoking Dependence Scale was 
used to determine nicotine dependence.15 A smoking-
specific stage of change questionnaire was used to stratify 
participants according to their motivation to quit 
smoking.16 
 
Intervention 
Participants in both groups were given brief smoking 
cessation advice as per The Royal Australian College of 
General Practitioners (RACGP) guidelines.17 The 
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intervention group also received the APRIL Age 
Progression Software intervention. The program uses a 
digital picture of the participant’s face, and ages the 
picture through the use of wrinkling/ageing algorithms. 
The algorithms are based on photographs of 2,000 people 
and on published data regarding facial changes associated 
with ageing.18 The software is designed to produce two 
versions of the participant’s face: one in which the 
participant ages as a non-smoker and one in which the 
participant’s face demonstrates the effects of smoking on 
aging (Figure 1). Participants view these effects in real-
time, as their face morphs throughout the process. 
 
Primary Outcomes 
The primary outcomes of the study were measured at six 
weeks’ post-intervention by telephone. They included the 
number of quit attempts made by the participant, 
nicotine dependence using the Fagerström Smoking 
Dependence Scale, and progression through the stages of 
change model. 
 
Data Analysis 
SPSS Version 23 (IBM Corp. Armonk, NY) was used for 
analysis at a significance level of p=0.05. Baseline 
demographics, nicotine dependence, and stage of change 
were compared between the two groups using Chi-square 
for categorical variables and Mann-Whitney U test for 
continuous variables. The primary outcomes at six weeks’ 
post-intervention were analysed using Mann-Whitney U 
test to compare the number of quit attempts and nicotine 
dependence and Chi-square test for stage of change. 
 
RESULTS 
One hundred and twenty-seven patients were screened 
for eligibility of which 30 met the inclusion and were 
enrolled into the study. Ninety-seven patients were 
excluded from the study, of which 93 were non-smokers 
and four declined to take part in the study. Fifteen 
participants were recruited into the intervention group 
and 15 into the control group. Five participants in the 
intervention group (33.33 per cent) and two participants 
in the control group (13.33 per cent) were lost to follow-
up. 
 
The baseline demographics of the two groups are 
illustrated in Table 1. There were no statistically 
significant differences in baseline demographics between 
the groups. The mean age was 27.53 in the intervention 
group and 28.2 in the control group (p=0.717). There 
were slightly more males in the intervention group and 
slightly more females in the control group, but this was 
not statistically significant (p=0.464).  
 
The baseline number of cigarettes smoked, nicotine 
dependence, and stage of change are depicted in Table 2. 
There were no differences in baseline outcome measures 
between the groups. The intervention group contained 
fewer light smokers and one heavy smoker. However, this 
was not statistically significant (Mann-Whitney U=94.5 
and p=0.230). There were no differences in baseline 
nicotine dependence or stage of change between the 
groups. The control group contained more participants 
with moderate nicotine dependence; however, this was 
not statistically significant (Mann-Whitney U= 111 and 
p=0.484).  
 
Primary Outcomes 
At six weeks’ post-intervention, the three outcome 
measures were compared between the intervention and 
control groups (Table 3). The intervention group 
recorded two quit attempts while the control group had 
three. This finding was not statistically significant (Mann-
Whitney U=111 and p=0 .484). Half of the participants 
in the intervention group experienced a reduction in 
nicotine dependence, while 15 per cent of the control 
group reduced their nicotine dependence. Although this 
was intriguing, the results were not statistically significant 
(Mann-Whitney U=106 and p=0.403). Furthermore, the 
groups showed no statistical difference in stage of change 
after the intervention (2=1.71 and p=0.634).  
 
DISCUSSION 
Our findings suggest that while it is possible to deliver 
photoageing technology in the hospital setting, 
hospitalisation introduces a number of challenges. 
Difficulties in recruitment, high attrition rates, and a lack 
of measureable effect suggest that this intervention is 
better suited to other clinical environments.  
 
In Australia, young adults are infrequently admitted to 
hospital. People aged 20–34 comprise only 12.7 per cent 
of hospital admissions each year.19 Furthermore, young 
people aged 15–34 account for only 25 per cent of all 
emergency department presentations.20 Therefore, young 
adults make up a small proportion of patients within the 
hospital system. Hence, recruiting young adult smokers 
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to this study was a challenging prospect. This was 
reflected in the small sample size of 30 participants.  
 
The small sample size was compounded by high rates of 
attrition. Approximately 25 per cent of participants were 
lost to follow-up. This is in keeping with previous studies 
on photoageing technology.11,12 The small sample size and 
high rates of attrition had serious implications on our 
study’s findings. We found that photoageing technology 
did not increase the number of quit attempts made by 
young adult smokers admitted to hospital. It can be 
argued that the study was insufficiently powered to detect 
a measurable difference between the groups. A type two 
error is therefore possible. However, alternative 
explanations must be considered. We propose that this 
lack of measureable effect may be related to the absence 
of a teachable moment. 
 
We hypothesise that the majority of our cohort did not 
experience a teachable moment during their hospital 
admission. Our findings suggest that this was influenced 
by three key factors: stage of change; reason for 
admission; and the setting. The participant’s stage of 
change was an important predictor of a quit attempt. Our 
findings demonstrate that patients in the pre-
contemplation stage are unlikely to make a quit attempt. 
Previous research on behavioural change supports this 
notion and emphasises the need for high levels of 
motivation to trigger behavioural change.21 This indicates 
that screening patients for stage of change may help to 
identify those most likely to respond to smoking cessation 
interventions. This notion is supported by the current 
RACGP smoking cessation guidelines.17 
 
We postulated that patients who are admitted to hospital 
with a condition related to their smoking are more likely 
to stop smoking or reduce their nicotine dependence. 
Previous research has demonstrated that in order for a 
teachable moment to occur, the inciting event must 
increase the patient’s sense of vulnerability.12 Therefore, 
patients admitted to hospital with a smoking-related 
illness may feel vulnerable to the adverse effects of 
cigarette smoke and experience a teachable moment. 
Conversely, patients admitted with pathologies unrelated 
to their smoking may not experience the same trigger. 
 
Every hospital contains multiple environments and not 
all are conducive to implementing this intervention. 
Throughout recruitment, we found it difficult to engage 
with participants in the emergency department. This is 
unsurprising for a number of reasons. First, most patients 
present to the emergency department because they deem 
their symptoms to be serious or life-threatening.22,23 As a 
result, they are anxious, distressed, and focused on their 
presenting complaint.23 Second, the chaotic, cramped, 
and communal environment often hampered 
communication. Therefore, we postulate that these 
personal and environmental factors contributed to poor 
patient engagement in our study. Subsequently, this 
intervention is better suited to other clinical 
environments. 
 
Despite the aforementioned difficulties encountered, this 
study produced a number of intriguing results. Our study 
found that approximately 50 per cent of participants in 
the intervention group reduced their nicotine 
dependence. Reducing nicotine dependence is an 
important step towards making a quit attempt. In fact, 
smokers with a lower level of dependence are more likely 
to make a quit attempt.24 
 
One of the strengths of this study was the inclusion of 
both male and female participants. Originally, 
photoageing technology was designed specifically for 
women. Subsequently, only one previous trial has 
evaluated the efficacy of this intervention in males. Our 
study found the intervention to be just as efficacious in 
males and females, with two males making a quit attempt 
and three females. This is in keeping with the previous 
study and lends weight to the argument that males can 
benefit from this technology.10 
 
There were four key limitations of this study. First, the 
use of subjective outcome measures is prone to reporting 
bias. Subsequently, future research should endeavour to 
biochemically confirm self-reported quit attempts 
through the use of salivary cotinine tests or carbon 
monoxide breath testing. Second, the study would have 
benefited from a longer follow-up period of three to six 
months. Third, generalisation of our results is limited as 
this was a single centre study conducted in the outer 
suburbs of Melbourne. Finally, the study had a small 
number of participants and high attrition rate. With such 
small numbers, we cannot show an effect size with any 
real degree of confidence.  
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In comparing our study to previous research using 
photoageing technology, we noted the incongruence of 
our findings. However, this pattern has been observed in 
other novel smoking cessation interventions. Internet-
based interventions have produced inconsistent results, 
underpinned by heterogeneous methodology.7 Similarly, 
mobile phone based interventions have produced mixed 
long-term benefits.9 iPhone apps have been hampered by 
a lack of evidence-based interventions, resulting in poor 
quality evidence.25 This indicates that photoageing 
technology, along with other technologies, require 
further investigation to validate their efficacy. 
 
Nevertheless, our findings have important clinical 
implications. We have demonstrated that while 
photoageing technology can be delivered in the hospital 
environment, the setting poses a number of challenges. 
Young adult smokers are infrequently admitted to 
hospital. Of those admitted, very few are sufficiently 
motivated to quit smoking. Therefore, we cannot 
recommend implementing this intervention in a general 
hospital setting. Furthermore, our findings suggest that 
patients in the pre-contemplation stage are unlikely to 
respond to smoking cessation interventions. Therefore, it 
may be beneficial to screen patients for stage of change to 
select those most likely to respond to treatment.  
 
Ultimately, further research is required to validate the 
efficacy of this intervention. There is potential value in 
expanding this technology in other settings, such as 
general practice and allied health clinics. With the advent 
of smart phones, a study investigating the efficacy of a 
smart phone app would provide an intriguing insight into 
the necessity for face-to-face interventions. Generation Y 
is known for its love of technology and the ability to 
interact electronically may be a key component for 
engagement in efficacious smoking cessation 
interventions. 
 
CONCLUSION 
Promoting behavioural change in young adult smokers is 
challenging. Hospitalisation is associated with a number 
of barriers, which prevent the implementation of 
photoageing technology in this setting. Of these barriers, 
participant recruitment and retention pose the greatest 
challenge. Due to these considerations, it was not 
possible to demonstrate an effect size with any 
confidence. However, there may be benefit in screening 
patients for stage of change if only to select those who 
may respond to triggering interventions. 
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  Figure 1: Digitally aged photos of a male at 72 years as a non-smoker (middle) and as a smoker (right) 
 
 
Note: The imaged used here is one of the authors, not a participant from the study. It has been used simply to show 
how the April Age technology ages a patient.  
 
Table 1: Baseline demographics 
 
Variable Intervention Group 
(n=15) 
Control Group 
(n=15) 
P value 
Age mean (SD) 27.53 (4.58) 28.2 (5.26) 0.717a 
    
Gender, n (%)    
Male 9 (60) 7 (46.67) 0.464b 
Female 6 (40) 8 (53.33)  
a T-test; b Chi-square 
 
Table 2: Baseline outcome measures 
 
Variable Intervention 
Group (n=15) 
Control Group 
(n=15) 
P value 
Number of cigarettes Smoked, n (%)    
<14 (light smokers) 8 (53.33) 10 (66.67)  
15–25 (moderate smokers) 6 (40) 5 (33.33)  
>25 (heavy smokers) 1 (6.67) 0 (0)  
Cigarettes smoked Median 13 13 0.230a 
    
Fagerstrom Nicotine Dependence Scale, 
n (%) 
   
1–2 (Low) 5 (33.33) 4 (26.67)  
3–4 (Low to moderate) 5 (33.33) 4 (26.67)  
5–7 (Moderate) 4 (26.67) 7 (46.67)  
>8 (High)  1 (6.67) 0 (0)  
Median  4 3 0.484a 
    
Stage of Change, n (%)   0.915b 
Pre-contemplation 4 (26.67) 5 (33.33)  
Contemplation 8 (53.33) 7 (46.67)  
Preparation 3 (20) 3 (20)  
Action 0 (0) 0 (0)  
Maintenance 0 (0) 0 (0)  
a Mann-Whitney U Test; b Chi-square 
 
 
 
 
       9 
JHD 2017:2(2):3–9 RESEARCH 
 
 
Figure 3: Primary outcomes 
 
Variable Intervention 
Group (n=15) 
Control Group 
(n=15) 
P value 
Number of Quit Attempts, n (%) 2 (13.33) 3 (20) 0.484a 
    
Fagerstrom Nicotine Dependence 
Scale, n (%) 
   
0 (No Dependence) 1 (6.67) 1 (6.67)  
1-2 (Low) 7 (46.67) 5 (33.33)  
3-4 (Low to moderate) 2 (13.33) 4 (26.67)  
5-7 (Moderate) 4(26.67) 5 (33.33)  
>8 (High)  1 (6.67) 0 (0)  
Median  2 3 0.403a 
    
Change in Fagerstrom Dependence 
Score, n (%) 
   
Reduced Dependence 4 (26.67) 2 (13.33)  
No Change 11 (73.33) 13 (86.67)  
Increased Dependence 0 (0) 0 (0)  
    
Stage of Change, n (%)   0.634b 
Pre-contemplation 4 (26.67) 5 (33.33)  
Contemplation 9 (60) 6 (40)  
Preparation 1 (6.67) 3 (20)  
Action 1 (6.67) 1 (6.67)  
Maintenance  0 (0) 0 (0) . 
a Mann-Whitney U Test; b Chi-square 
 
